These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34293534)

  • 1. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.
    Fabbri M; Leung C; Baille G; Béreau M; Brefel Courbon C; Castelnovo G; Carriere N; Damier P; Defebvre L; Doe de Maindreville A; Fluchere F; Fuzzatti M; Grabli D; Maltete D; Rousseau V; Sommet A A; Thalamas C; Thiriez C; Rascol O; Ory-Magne F
    Parkinsonism Relat Disord; 2021 Aug; 89():128-133. PubMed ID: 34293534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 on palliative care for people with Parkinson's and response to future pandemics.
    Chaudhuri KR; Rukavina K; McConvey V; Antonini A; Lorenzl S; Bhidayasiri R; Piemonte MEP; Lim SY; Richfield E; Walker R; Bouca-Machado R; Bajwah S; Gao W; Trivedi D; Miyasaki J
    Expert Rev Neurother; 2021 Jun; 21(6):615-623. PubMed ID: 33905283
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown.
    Luis-Martínez R; Di Marco R; Weis L; Cianci V; Pistonesi F; Baba A; Carecchio M; Biundo R; Tedesco C; Masiero S; Antonini A
    BMC Neurol; 2021 Aug; 21(1):332. PubMed ID: 34461838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lockdown effects on Parkinson's disease during COVID-19 pandemic: a pilot study.
    Falla M; Dodich A; Papagno C; Gober A; Narduzzi P; Pierotti E; Falk M; Zappini F; Colosimo C; Turella L
    Acta Neurol Belg; 2021 Oct; 121(5):1191-1198. PubMed ID: 34212285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson's Disease.
    van der Heide A; Meinders MJ; Bloem BR; Helmich RC
    J Parkinsons Dis; 2020; 10(4):1355-1364. PubMed ID: 32925108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
    Del Prete E; Francesconi A; Palermo G; Mazzucchi S; Frosini D; Morganti R; Coleschi P; Raglione LM; Vanni P; Ramat S; Novelli A; Napolitano A; Battisti C; Giuntini M; Rossi C; Menichetti C; Ulivelli M; De Franco V; Rossi S; Bonuccelli U; Ceravolo R;
    J Neurol; 2021 Apr; 268(4):1179-1187. PubMed ID: 32880722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and Covid-19: The effect and use of telemedicine.
    Podlewska AM; van Wamelen DJ
    Int Rev Neurobiol; 2022; 165():263-281. PubMed ID: 36208904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care.
    Rukavina K; McConvey V; Ray Chaudhuri K; Miyasaki J
    Int Rev Neurobiol; 2022; 165():229-249. PubMed ID: 36208902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life with Parkinson's Disease During the COVID-19 Pandemic: The Pressure Is "OFF".
    HØrmann Thomsen T; Wallerstedt SM; Winge K; Bergquist F
    J Parkinsons Dis; 2021; 11(2):491-495. PubMed ID: 33459663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life and disease status of patients with Parkinson's disease during and after zero-COVID in China: an online survey.
    Huang P; Tan YY; Chen B; Shang HF; Wang LJ; Liu CF; Chen L; Chang Y; Wang H; Wang XL; Lei XG; Yao LF; Yu Y; Ye Z; Chen HB; Chen SD
    Transl Neurodegener; 2024 Feb; 13(1):8. PubMed ID: 38317265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening of Parkinson's Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy.
    Ineichen C; Vogel-Baumann H; Sitzler M; Deuschl G; Baumann CR
    J Parkinsons Dis; 2023; 13(5):845-848. PubMed ID: 37270811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration of people with Parkinson's symptoms during COVID-19 lockdown: results of a web-based survey in Northwestern Italy.
    Cosentino M; Pinoli M; Uslenghi M; Pennisi M; Maldacea G; Comi C; Marino F
    Aging Ment Health; 2024 Aug; ():1-8. PubMed ID: 39113597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic.
    Ketigian L; Piniella N; McGivney K; Lui S; Dukat A; Jung MK; Gallagher R; Leder A
    Front Public Health; 2021; 9():772805. PubMed ID: 35186865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson's Disease: A PMD Alliance Survey.
    Hermanowicz N; Ospina MC; Torres-Yaghi Y; Gould S; Papesh K; Rivera JA; Miller S; Jones S; Musick K; May D
    Neuropsychiatr Dis Treat; 2022; 18():633-643. PubMed ID: 35355505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease.
    Poonja S; Chaudhuri KR; Miyasaki JM
    Curr Opin Neurol; 2022 Aug; 35(4):494-501. PubMed ID: 35787539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey.
    Hermanowicz N; Jones SA; Hauser RA
    Neuropsychiatr Dis Treat; 2019; 15():2205-2212. PubMed ID: 31496703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's patients situation during the SARS CoV-2 pandemic and their interest in telemedicine A cross-sectional study.
    Witt VD; Baur G; Ecke J; Kirchner A; Hauptmann B
    PLoS One; 2021; 16(12):e0260317. PubMed ID: 34855794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on physical activity, anxiety, and depression in patients with Parkinson's disease.
    Balci B; Aktar B; Buran S; Tas M; Donmez Colakoglu B
    Int J Rehabil Res; 2021 Jun; 44(2):173-176. PubMed ID: 33653991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New Zealand.
    Blakemore RL; Pascoe MJ; Horne KL; Livingston L; Young BN; Elias B; Goulden M; Grenfell S; Myall DJ; Pitcher TL; Dalrymple-Alford JC; Le Heron CJ; Anderson TJ; MacAskill MR
    N Z Med J; 2021 Jul; 134(1538):44-51. PubMed ID: 34239144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment paradigms in Parkinson's Disease and Covid-19.
    Boura I; Batzu L; Dietrichs E; Ray Chaudhuri K
    Int Rev Neurobiol; 2022; 165():135-171. PubMed ID: 36208898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.